{"entity":{"type":"insider","cik":"0001377247","url":"/insider/0001377247","json_url":"/insider/0001377247.json","name":"Powchik Peter","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":54,"n_filings":12,"first":"2011-07-26","last":"2015-08-17","span_basis":"filed_date"},"name_variants":[{"name":"Powchik Peter","source":"filing","n_filings":12,"first_seen":"2011-07-26","last_seen":"2015-08-17"}],"transactions":[{"id":8906915,"accession":"0001237899-15-000049","txn_seq":25,"anchor":"line-25","filing_url":"/filing/0001237899-15-000049","line_url":"/filing/0001237899-15-000049#line-25","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS INC","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001377247","owner_name":"Powchik Peter","owner_url":"/insider/0001377247","role":"Officer (SVP Clinical Development & Reg)","officer_title":"SVP Clinical Development & Reg","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5598.0,"shares_display":"5,598","price_per_share":571.54,"price_display":"571.54","price_state":"stated","total_value":3199480.92,"total_display":"3,199,480.92","shares_owned_after":28700.0,"shares_owned_after_display":"28,700","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-14","filed_date":"2015-08-17","scope":"insider"},{"id":8906913,"accession":"0001237899-15-000049","txn_seq":24,"anchor":"line-24","filing_url":"/filing/0001237899-15-000049","line_url":"/filing/0001237899-15-000049#line-24","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS INC","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001377247","owner_name":"Powchik Peter","owner_url":"/insider/0001377247","role":"Officer (SVP Clinical Development & Reg)","officer_title":"SVP Clinical Development & Reg","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3603.0,"shares_display":"3,603","price_per_share":570.63,"price_display":"570.63","price_state":"stated","total_value":2055979.89,"total_display":"2,055,979.89","shares_owned_after":34298.0,"shares_owned_after_display":"34,298","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-14","filed_date":"2015-08-17","scope":"insider"},{"id":8906911,"accession":"0001237899-15-000049","txn_seq":23,"anchor":"line-23","filing_url":"/filing/0001237899-15-000049","line_url":"/filing/0001237899-15-000049#line-23","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS INC","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001377247","owner_name":"Powchik Peter","owner_url":"/insider/0001377247","role":"Officer (SVP Clinical Development & Reg)","officer_title":"SVP Clinical Development & Reg","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2800.0,"shares_display":"2,800","price_per_share":572.6,"price_display":"572.60","price_state":"stated","total_value":1603280.0,"total_display":"1,603,280.00","shares_owned_after":25900.0,"shares_owned_after_display":"25,900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-14","filed_date":"2015-08-17","scope":"insider"},{"id":8906910,"accession":"0001237899-15-000049","txn_seq":22,"anchor":"line-22","filing_url":"/filing/0001237899-15-000049","line_url":"/filing/0001237899-15-000049#line-22","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS INC","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001377247","owner_name":"Powchik Peter","owner_url":"/insider/0001377247","role":"Officer (SVP Clinical Development & Reg)","officer_title":"SVP Clinical Development & Reg","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2717.0,"shares_display":"2,717","price_per_share":573.64,"price_display":"573.64","price_state":"stated","total_value":1558579.88,"total_display":"1,558,579.88","shares_owned_after":23183.0,"shares_owned_after_display":"23,183","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-14","filed_date":"2015-08-17","scope":"insider"},{"id":8906909,"accession":"0001237899-15-000049","txn_seq":21,"anchor":"line-21","filing_url":"/filing/0001237899-15-000049","line_url":"/filing/0001237899-15-000049#line-21","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS INC","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001377247","owner_name":"Powchik Peter","owner_url":"/insider/0001377247","role":"Officer (SVP Clinical Development & Reg)","officer_title":"SVP Clinical Development & Reg","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2258.0,"shares_display":"2,258","price_per_share":577.75,"price_display":"577.75","price_state":"stated","total_value":1304559.5,"total_display":"1,304,559.50","shares_owned_after":17321.0,"shares_owned_after_display":"17,321","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-14","filed_date":"2015-08-17","scope":"insider"},{"id":8906907,"accession":"0001237899-15-000049","txn_seq":20,"anchor":"line-20","filing_url":"/filing/0001237899-15-000049","line_url":"/filing/0001237899-15-000049#line-20","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS INC","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001377247","owner_name":"Powchik Peter","owner_url":"/insider/0001377247","role":"Officer (SVP Clinical Development & Reg)","officer_title":"SVP Clinical Development & Reg","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2004.0,"shares_display":"2,004","price_per_share":576.65,"price_display":"576.65","price_state":"stated","total_value":1155606.6,"total_display":"1,155,606.60","shares_owned_after":19579.0,"shares_owned_after_display":"19,579","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-14","filed_date":"2015-08-17","scope":"insider"},{"id":8906906,"accession":"0001237899-15-000049","txn_seq":19,"anchor":"line-19","filing_url":"/filing/0001237899-15-000049","line_url":"/filing/0001237899-15-000049#line-19","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS INC","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001377247","owner_name":"Powchik Peter","owner_url":"/insider/0001377247","role":"Officer (SVP Clinical Development & Reg)","officer_title":"SVP Clinical Development & Reg","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":578.63,"price_display":"578.63","price_state":"stated","total_value":867945.0,"total_display":"867,945.00","shares_owned_after":15821.0,"shares_owned_after_display":"15,821","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-14","filed_date":"2015-08-17","scope":"insider"},{"id":8906904,"accession":"0001237899-15-000049","txn_seq":18,"anchor":"line-18","filing_url":"/filing/0001237899-15-000049","line_url":"/filing/0001237899-15-000049#line-18","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS INC","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001377247","owner_name":"Powchik Peter","owner_url":"/insider/0001377247","role":"Officer (SVP Clinical Development & Reg)","officer_title":"SVP Clinical Development & Reg","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1405.0,"shares_display":"1,405","price_per_share":569.63,"price_display":"569.63","price_state":"stated","total_value":800330.15,"total_display":"800,330.15","shares_owned_after":37901.0,"shares_owned_after_display":"37,901","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-14","filed_date":"2015-08-17","scope":"insider"},{"id":8906903,"accession":"0001237899-15-000049","txn_seq":17,"anchor":"line-17","filing_url":"/filing/0001237899-15-000049","line_url":"/filing/0001237899-15-000049#line-17","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS INC","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001377247","owner_name":"Powchik Peter","owner_url":"/insider/0001377247","role":"Officer (SVP Clinical Development & Reg)","officer_title":"SVP Clinical Development & Reg","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":900.0,"shares_display":"900","price_per_share":574.75,"price_display":"574.75","price_state":"stated","total_value":517275.0,"total_display":"517,275.00","shares_owned_after":22283.0,"shares_owned_after_display":"22,283","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-14","filed_date":"2015-08-17","scope":"insider"},{"id":8906901,"accession":"0001237899-15-000049","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001237899-15-000049","line_url":"/filing/0001237899-15-000049#line-16","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS INC","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001377247","owner_name":"Powchik Peter","owner_url":"/insider/0001377247","role":"Officer (SVP Clinical Development & Reg)","officer_title":"SVP Clinical Development & Reg","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":700.0,"shares_display":"700","price_per_share":575.47,"price_display":"575.47","price_state":"stated","total_value":402829.0,"total_display":"402,829.00","shares_owned_after":21583.0,"shares_owned_after_display":"21,583","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-14","filed_date":"2015-08-17","scope":"insider"},{"id":8333452,"accession":"0001237899-15-000011","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001237899-15-000011","line_url":"/filing/0001237899-15-000011#line-11","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS INC","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001377247","owner_name":"Powchik Peter","owner_url":"/insider/0001377247","role":"Officer (SVP Clinical Development & Reg)","officer_title":"SVP Clinical Development & Reg","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2758.0,"shares_display":"2,758","price_per_share":414.07,"price_display":"414.07","price_state":"stated","total_value":1142005.06,"total_display":"1,142,005.06","shares_owned_after":14553.0,"shares_owned_after_display":"14,553","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-02","filed_date":"2015-01-05","scope":"insider"},{"id":8333447,"accession":"0001237899-15-000011","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001237899-15-000011","line_url":"/filing/0001237899-15-000011#line-10","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS INC","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001377247","owner_name":"Powchik Peter","owner_url":"/insider/0001377247","role":"Officer (SVP Clinical Development & Reg)","officer_title":"SVP Clinical Development & Reg","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1700.0,"shares_display":"1,700","price_per_share":412.81,"price_display":"412.81","price_state":"stated","total_value":701777.0,"total_display":"701,777.00","shares_owned_after":17311.0,"shares_owned_after_display":"17,311","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-02","filed_date":"2015-01-05","scope":"insider"},{"id":8333444,"accession":"0001237899-15-000011","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001237899-15-000011","line_url":"/filing/0001237899-15-000011#line-9","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS INC","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001377247","owner_name":"Powchik Peter","owner_url":"/insider/0001377247","role":"Officer (SVP Clinical Development & Reg)","officer_title":"SVP Clinical Development & Reg","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1642.0,"shares_display":"1,642","price_per_share":415.2,"price_display":"415.20","price_state":"stated","total_value":681758.4,"total_display":"681,758.40","shares_owned_after":12911.0,"shares_owned_after_display":"12,911","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-02","filed_date":"2015-01-05","scope":"insider"},{"id":8333440,"accession":"0001237899-15-000011","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001237899-15-000011","line_url":"/filing/0001237899-15-000011#line-8","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS INC","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001377247","owner_name":"Powchik Peter","owner_url":"/insider/0001377247","role":"Officer (SVP Clinical Development & Reg)","officer_title":"SVP Clinical Development & Reg","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1400.0,"shares_display":"1,400","price_per_share":410.99,"price_display":"410.99","price_state":"stated","total_value":575386.0,"total_display":"575,386.00","shares_owned_after":20133.0,"shares_owned_after_display":"20,133","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-02","filed_date":"2015-01-05","scope":"insider"},{"id":8333436,"accession":"0001237899-15-000011","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001237899-15-000011","line_url":"/filing/0001237899-15-000011#line-7","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS INC","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001377247","owner_name":"Powchik Peter","owner_url":"/insider/0001377247","role":"Officer (SVP Clinical Development & Reg)","officer_title":"SVP Clinical Development & Reg","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1122.0,"shares_display":"1,122","price_per_share":411.99,"price_display":"411.99","price_state":"stated","total_value":462252.78,"total_display":"462,252.78","shares_owned_after":19011.0,"shares_owned_after_display":"19,011","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-02","filed_date":"2015-01-05","scope":"insider"},{"id":8333428,"accession":"0001237899-15-000011","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001237899-15-000011","line_url":"/filing/0001237899-15-000011#line-6","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS INC","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001377247","owner_name":"Powchik Peter","owner_url":"/insider/0001377247","role":"Officer (SVP Clinical Development & Reg)","officer_title":"SVP Clinical Development & Reg","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":417.44,"price_display":"417.44","price_state":"stated","total_value":417440.0,"total_display":"417,440.00","shares_owned_after":11011.0,"shares_owned_after_display":"11,011","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-02","filed_date":"2015-01-05","scope":"insider"},{"id":8333425,"accession":"0001237899-15-000011","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001237899-15-000011","line_url":"/filing/0001237899-15-000011#line-5","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS INC","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001377247","owner_name":"Powchik Peter","owner_url":"/insider/0001377247","role":"Officer (SVP Clinical Development & Reg)","officer_title":"SVP Clinical Development & Reg","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":900.0,"shares_display":"900","price_per_share":416.75,"price_display":"416.75","price_state":"stated","total_value":375075.0,"total_display":"375,075.00","shares_owned_after":12011.0,"shares_owned_after_display":"12,011","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-02","filed_date":"2015-01-05","scope":"insider"},{"id":8333419,"accession":"0001237899-15-000011","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001237899-15-000011","line_url":"/filing/0001237899-15-000011#line-4","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS INC","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001377247","owner_name":"Powchik Peter","owner_url":"/insider/0001377247","role":"Officer (SVP Clinical Development & Reg)","officer_title":"SVP Clinical Development & Reg","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":418.4,"price_display":"418.40","price_state":"stated","total_value":125520.0,"total_display":"125,520.00","shares_owned_after":10711.0,"shares_owned_after_display":"10,711","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-02","filed_date":"2015-01-05","scope":"insider"},{"id":6832374,"accession":"0001237899-14-000001","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001237899-14-000001","line_url":"/filing/0001237899-14-000001#line-9","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS INC","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001377247","owner_name":"Powchik Peter","owner_url":"/insider/0001377247","role":"Officer (SVP Clinical Development & Reg)","officer_title":"SVP Clinical Development & Reg","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6893.0,"shares_display":"6,893","price_per_share":276.04,"price_display":"276.04","price_state":"stated","total_value":1902743.72,"total_display":"1,902,743.72","shares_owned_after":26843.0,"shares_owned_after_display":"26,843","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-02","filed_date":"2014-01-03","scope":"insider"},{"id":6832372,"accession":"0001237899-14-000001","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001237899-14-000001","line_url":"/filing/0001237899-14-000001#line-8","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS INC","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001377247","owner_name":"Powchik Peter","owner_url":"/insider/0001377247","role":"Officer (SVP Clinical Development & Reg)","officer_title":"SVP Clinical Development & Reg","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5602.0,"shares_display":"5,602","price_per_share":273.77,"price_display":"273.77","price_state":"stated","total_value":1533659.54,"total_display":"1,533,659.54","shares_owned_after":37513.0,"shares_owned_after_display":"37,513","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-02","filed_date":"2014-01-03","scope":"insider"},{"id":6832368,"accession":"0001237899-14-000001","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001237899-14-000001","line_url":"/filing/0001237899-14-000001#line-7","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS INC","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001377247","owner_name":"Powchik Peter","owner_url":"/insider/0001377247","role":"Officer (SVP Clinical Development & Reg)","officer_title":"SVP Clinical Development & Reg","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3777.0,"shares_display":"3,777","price_per_share":274.69,"price_display":"274.69","price_state":"stated","total_value":1037504.13,"total_display":"1,037,504.13","shares_owned_after":33736.0,"shares_owned_after_display":"33,736","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-02","filed_date":"2014-01-03","scope":"insider"},{"id":6832365,"accession":"0001237899-14-000001","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001237899-14-000001","line_url":"/filing/0001237899-14-000001#line-6","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS INC","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001377247","owner_name":"Powchik Peter","owner_url":"/insider/0001377247","role":"Officer (SVP Clinical Development & Reg)","officer_title":"SVP Clinical Development & Reg","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":272.88,"price_display":"272.88","price_state":"stated","total_value":818640.0,"total_display":"818,640.00","shares_owned_after":43115.0,"shares_owned_after_display":"43,115","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-02","filed_date":"2014-01-03","scope":"insider"},{"id":6832361,"accession":"0001237899-14-000001","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001237899-14-000001","line_url":"/filing/0001237899-14-000001#line-5","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS INC","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001377247","owner_name":"Powchik Peter","owner_url":"/insider/0001377247","role":"Officer (SVP Clinical Development & Reg)","officer_title":"SVP Clinical Development & Reg","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1296.0,"shares_display":"1,296","price_per_share":276.75,"price_display":"276.75","price_state":"stated","total_value":358668.0,"total_display":"358,668.00","shares_owned_after":25547.0,"shares_owned_after_display":"25,547","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-02","filed_date":"2014-01-03","scope":"insider"},{"id":6832357,"accession":"0001237899-14-000001","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001237899-14-000001","line_url":"/filing/0001237899-14-000001#line-4","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS INC","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001377247","owner_name":"Powchik Peter","owner_url":"/insider/0001377247","role":"Officer (SVP Clinical Development & Reg)","officer_title":"SVP Clinical Development & Reg","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":277.5,"price_display":"277.50","price_state":"stated","total_value":27750.0,"total_display":"27,750.00","shares_owned_after":25447.0,"shares_owned_after_display":"25,447","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-02","filed_date":"2014-01-03","scope":"insider"},{"id":4243036,"accession":"0001237899-13-000077","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001237899-13-000077","line_url":"/filing/0001237899-13-000077#line-5","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS INC","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001377247","owner_name":"Powchik Peter","owner_url":"/insider/0001377247","role":"Officer (SVP Clinical Development & Reg)","officer_title":"SVP Clinical Development & Reg","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":133.0,"shares_display":"133","price_per_share":271.09,"price_display":"271.09","price_state":"stated","total_value":36054.97,"total_display":"36,054.97","shares_owned_after":20742.0,"shares_owned_after_display":"20,742","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-12-20","filed_date":"2013-12-20","scope":"insider"},{"id":4243032,"accession":"0001237899-13-000077","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001237899-13-000077","line_url":"/filing/0001237899-13-000077#line-4","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS INC","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001377247","owner_name":"Powchik Peter","owner_url":"/insider/0001377247","role":"Officer (SVP Clinical Development & Reg)","officer_title":"SVP Clinical Development & Reg","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9000.0,"shares_display":"9,000","price_per_share":270.2,"price_display":"270.20","price_state":"stated","total_value":2431800.0,"total_display":"2,431,800.00","shares_owned_after":20742.0,"shares_owned_after_display":"20,742","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-12-18","filed_date":"2013-12-20","scope":"insider"},{"id":5544524,"accession":"0001237899-13-000072","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001237899-13-000072","line_url":"/filing/0001237899-13-000072#line-10","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS INC","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001377247","owner_name":"Powchik Peter","owner_url":"/insider/0001377247","role":"Officer (SVP Clinical Development & Reg)","officer_title":"SVP Clinical Development & Reg","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8.0,"shares_display":"8","price_per_share":270.0,"price_display":"270.00","price_state":"stated","total_value":2160.0,"total_display":"2,160.00","shares_owned_after":29742.0,"shares_owned_after_display":"29,742","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-12-17","filed_date":"2013-12-17","scope":"insider"},{"id":4946876,"accession":"0001237899-13-000010","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001237899-13-000010","line_url":"/filing/0001237899-13-000010#line-7","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS INC","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001377247","owner_name":"Powchik Peter","owner_url":"/insider/0001377247","role":"Officer (SVP Clin Devel & Reg Affairs)","officer_title":"SVP Clin Devel & Reg Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6200.0,"shares_display":"6,200","price_per_share":181.51,"price_display":"181.51","price_state":"stated","total_value":1125362.0,"total_display":"1,125,362.00","shares_owned_after":21590.0,"shares_owned_after_display":"21,590","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-01-03","filed_date":"2013-01-04","scope":"insider"},{"id":4946868,"accession":"0001237899-13-000010","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001237899-13-000010","line_url":"/filing/0001237899-13-000010#line-6","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS INC","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001377247","owner_name":"Powchik Peter","owner_url":"/insider/0001377247","role":"Officer (SVP Clin Devel & Reg Affairs)","officer_title":"SVP Clin Devel & Reg Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4300.0,"shares_display":"4,300","price_per_share":183.1,"price_display":"183.10","price_state":"stated","total_value":787330.0,"total_display":"787,330.00","shares_owned_after":14990.0,"shares_owned_after_display":"14,990","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-01-03","filed_date":"2013-01-04","scope":"insider"},{"id":4946864,"accession":"0001237899-13-000010","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001237899-13-000010","line_url":"/filing/0001237899-13-000010#line-5","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS INC","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001377247","owner_name":"Powchik Peter","owner_url":"/insider/0001377247","role":"Officer (SVP Clin Devel & Reg Affairs)","officer_title":"SVP Clin Devel & Reg Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2300.0,"shares_display":"2,300","price_per_share":182.29,"price_display":"182.29","price_state":"stated","total_value":419267.0,"total_display":"419,267.00","shares_owned_after":19290.0,"shares_owned_after_display":"19,290","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-01-03","filed_date":"2013-01-04","scope":"insider"},{"id":4946860,"accession":"0001237899-13-000010","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001237899-13-000010","line_url":"/filing/0001237899-13-000010#line-4","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS INC","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001377247","owner_name":"Powchik Peter","owner_url":"/insider/0001377247","role":"Officer (SVP Clin Devel & Reg Affairs)","officer_title":"SVP Clin Devel & Reg Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":786.0,"shares_display":"786","price_per_share":180.83,"price_display":"180.83","price_state":"stated","total_value":142132.38,"total_display":"142,132.38","shares_owned_after":27790.0,"shares_owned_after_display":"27,790","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-01-03","filed_date":"2013-01-04","scope":"insider"},{"id":3093410,"accession":"0001237899-12-000110","txn_seq":18,"anchor":"line-18","filing_url":"/filing/0001237899-12-000110","line_url":"/filing/0001237899-12-000110#line-18","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS INC","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001377247","owner_name":"Powchik Peter","owner_url":"/insider/0001377247","role":"Officer (SVP Clin Devel & Reg Affairs)","officer_title":"SVP Clin Devel & Reg Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4623.0,"shares_display":"4,623","price_per_share":170.44,"price_display":"170.44","price_state":"stated","total_value":787944.12,"total_display":"787,944.12","shares_owned_after":16990.0,"shares_owned_after_display":"16,990","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-12-20","filed_date":"2012-12-20","scope":"insider"},{"id":3093406,"accession":"0001237899-12-000110","txn_seq":17,"anchor":"line-17","filing_url":"/filing/0001237899-12-000110","line_url":"/filing/0001237899-12-000110#line-17","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS INC","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001377247","owner_name":"Powchik Peter","owner_url":"/insider/0001377247","role":"Officer (SVP Clin Devel & Reg Affairs)","officer_title":"SVP Clin Devel & Reg Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":171.11,"price_display":"171.11","price_state":"stated","total_value":342220.0,"total_display":"342,220.00","shares_owned_after":14990.0,"shares_owned_after_display":"14,990","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-12-20","filed_date":"2012-12-20","scope":"insider"},{"id":3093403,"accession":"0001237899-12-000110","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001237899-12-000110","line_url":"/filing/0001237899-12-000110#line-16","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS INC","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001377247","owner_name":"Powchik Peter","owner_url":"/insider/0001377247","role":"Officer (SVP Clin Devel & Reg Affairs)","officer_title":"SVP Clin Devel & Reg Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4266.0,"shares_display":"4,266","price_per_share":177.52,"price_display":"177.52","price_state":"stated","total_value":757300.32,"total_display":"757,300.32","shares_owned_after":26669.0,"shares_owned_after_display":"26,669","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-12-19","filed_date":"2012-12-20","scope":"insider"},{"id":3093400,"accession":"0001237899-12-000110","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001237899-12-000110","line_url":"/filing/0001237899-12-000110#line-15","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS INC","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001377247","owner_name":"Powchik Peter","owner_url":"/insider/0001377247","role":"Officer (SVP Clin Devel & Reg Affairs)","officer_title":"SVP Clin Devel & Reg Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2200.0,"shares_display":"2,200","price_per_share":178.33,"price_display":"178.33","price_state":"stated","total_value":392326.0,"total_display":"392,326.00","shares_owned_after":24469.0,"shares_owned_after_display":"24,469","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-12-19","filed_date":"2012-12-20","scope":"insider"},{"id":3093395,"accession":"0001237899-12-000110","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001237899-12-000110","line_url":"/filing/0001237899-12-000110#line-14","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS INC","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001377247","owner_name":"Powchik Peter","owner_url":"/insider/0001377247","role":"Officer (SVP Clin Devel & Reg Affairs)","officer_title":"SVP Clin Devel & Reg Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1256.0,"shares_display":"1,256","price_per_share":180.62,"price_display":"180.62","price_state":"stated","total_value":226858.72,"total_display":"226,858.72","shares_owned_after":22213.0,"shares_owned_after_display":"22,213","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-12-19","filed_date":"2012-12-20","scope":"insider"},{"id":3093386,"accession":"0001237899-12-000110","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001237899-12-000110","line_url":"/filing/0001237899-12-000110#line-13","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS INC","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001377247","owner_name":"Powchik Peter","owner_url":"/insider/0001377247","role":"Officer (SVP Clin Devel & Reg Affairs)","officer_title":"SVP Clin Devel & Reg Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1034.0,"shares_display":"1,034","price_per_share":176.79,"price_display":"176.79","price_state":"stated","total_value":182800.86,"total_display":"182,800.86","shares_owned_after":30935.0,"shares_owned_after_display":"30,935","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-12-19","filed_date":"2012-12-20","scope":"insider"},{"id":3093383,"accession":"0001237899-12-000110","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001237899-12-000110","line_url":"/filing/0001237899-12-000110#line-12","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS INC","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001377247","owner_name":"Powchik Peter","owner_url":"/insider/0001377247","role":"Officer (SVP Clin Devel & Reg Affairs)","officer_title":"SVP Clin Devel & Reg Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":179.56,"price_display":"179.56","price_state":"stated","total_value":179560.0,"total_display":"179,560.00","shares_owned_after":23469.0,"shares_owned_after_display":"23,469","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-12-19","filed_date":"2012-12-20","scope":"insider"},{"id":3093379,"accession":"0001237899-12-000110","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001237899-12-000110","line_url":"/filing/0001237899-12-000110#line-11","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS INC","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001377247","owner_name":"Powchik Peter","owner_url":"/insider/0001377247","role":"Officer (SVP Clin Devel & Reg Affairs)","officer_title":"SVP Clin Devel & Reg Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":183.13,"price_display":"183.13","price_state":"stated","total_value":91565.0,"total_display":"91,565.00","shares_owned_after":21613.0,"shares_owned_after_display":"21,613","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-12-19","filed_date":"2012-12-20","scope":"insider"},{"id":3093375,"accession":"0001237899-12-000110","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001237899-12-000110","line_url":"/filing/0001237899-12-000110#line-10","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS INC","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001377247","owner_name":"Powchik Peter","owner_url":"/insider/0001377247","role":"Officer (SVP Clin Devel & Reg Affairs)","officer_title":"SVP Clin Devel & Reg Affairs","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":181.25,"price_display":"181.25","price_state":"stated","total_value":18125.0,"total_display":"18,125.00","shares_owned_after":22113.0,"shares_owned_after_display":"22,113","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-12-19","filed_date":"2012-12-20","scope":"insider"},{"id":2474703,"accession":"0001556247-12-000003","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001556247-12-000003","line_url":"/filing/0001556247-12-000003#line-2","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS INC","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001377247","owner_name":"Powchik Peter","owner_url":"/insider/0001377247","role":"Officer (SVP Clinical Development & Reg)","officer_title":"SVP Clinical Development & Reg","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14244.0,"shares_display":"14,244","price_per_share":138.59,"price_display":"138.59","price_state":"stated","total_value":1974075.96,"total_display":"1,974,075.96","shares_owned_after":15890.0,"shares_owned_after_display":"15,890","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-11-08","filed_date":"2012-11-09","scope":"insider"},{"id":2474698,"accession":"0001556247-12-000003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001556247-12-000003","line_url":"/filing/0001556247-12-000003#line-1","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS INC","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001377247","owner_name":"Powchik Peter","owner_url":"/insider/0001377247","role":"Officer (SVP Clinical Development & Reg)","officer_title":"SVP Clinical Development & Reg","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":900.0,"shares_display":"900","price_per_share":139.05,"price_display":"139.05","price_state":"stated","total_value":125145.0,"total_display":"125,145.00","shares_owned_after":14990.0,"shares_owned_after_display":"14,990","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-11-08","filed_date":"2012-11-09","scope":"insider"},{"id":3506963,"accession":"0001556247-12-000002","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001556247-12-000002","line_url":"/filing/0001556247-12-000002#line-6","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS INC","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001377247","owner_name":"Powchik Peter","owner_url":"/insider/0001377247","role":"Officer (SVP Clinical Development & Reg)","officer_title":"SVP Clinical Development & Reg","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3200.0,"shares_display":"3,200","price_per_share":147.16,"price_display":"147.16","price_state":"stated","total_value":470912.0,"total_display":"470,912.00","shares_owned_after":31134.0,"shares_owned_after_display":"31,134","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-09-19","filed_date":"2012-09-20","scope":"insider"},{"id":3506961,"accession":"0001556247-12-000002","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001556247-12-000002","line_url":"/filing/0001556247-12-000002#line-5","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS INC","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001377247","owner_name":"Powchik Peter","owner_url":"/insider/0001377247","role":"Officer (SVP Clinical Development & Reg)","officer_title":"SVP Clinical Development & Reg","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2977.0,"shares_display":"2,977","price_per_share":146.89,"price_display":"146.89","price_state":"stated","total_value":437291.53,"total_display":"437,291.53","shares_owned_after":34334.0,"shares_owned_after_display":"34,334","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-09-19","filed_date":"2012-09-20","scope":"insider"},{"id":3506959,"accession":"0001556247-12-000002","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001556247-12-000002","line_url":"/filing/0001556247-12-000002#line-4","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS INC","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001377247","owner_name":"Powchik Peter","owner_url":"/insider/0001377247","role":"Officer (SVP Clinical Development & Reg)","officer_title":"SVP Clinical Development & Reg","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":148.0,"price_display":"148.00","price_state":"stated","total_value":148000.0,"total_display":"148,000.00","shares_owned_after":30134.0,"shares_owned_after_display":"30,134","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-09-19","filed_date":"2012-09-20","scope":"insider"},{"id":3401416,"accession":"0001237899-12-000063","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001237899-12-000063","line_url":"/filing/0001237899-12-000063#line-5","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS INC","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001377247","owner_name":"Powchik Peter","owner_url":"/insider/0001377247","role":"Officer (SVP Clinical Development & Reg)","officer_title":"SVP Clinical Development & Reg","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4519.0,"shares_display":"4,519","price_per_share":130.4,"price_display":"130.40","price_state":"stated","total_value":589277.6,"total_display":"589,277.60","shares_owned_after":17644.0,"shares_owned_after_display":"17,644","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-07-26","filed_date":"2012-07-27","scope":"insider"},{"id":3401415,"accession":"0001237899-12-000063","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001237899-12-000063","line_url":"/filing/0001237899-12-000063#line-4","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS INC","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001377247","owner_name":"Powchik Peter","owner_url":"/insider/0001377247","role":"Officer (SVP Clinical Development & Reg)","officer_title":"SVP Clinical Development & Reg","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":131.07,"price_display":"131.07","price_state":"stated","total_value":327675.0,"total_display":"327,675.00","shares_owned_after":15144.0,"shares_owned_after_display":"15,144","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-07-26","filed_date":"2012-07-27","scope":"insider"},{"id":2583203,"accession":"0001237899-12-000030","txn_seq":17,"anchor":"line-17","filing_url":"/filing/0001237899-12-000030","line_url":"/filing/0001237899-12-000030#line-17","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS INC","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001377247","owner_name":"Powchik Peter","owner_url":"/insider/0001377247","role":"Officer (SVP Clinical Development & Reg)","officer_title":"SVP Clinical Development & Reg","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23454.0,"shares_display":"23,454","price_per_share":96.45,"price_display":"96.45","price_state":"stated","total_value":2262138.3,"total_display":"2,262,138.30","shares_owned_after":25944.0,"shares_owned_after_display":"25,944","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-02-22","filed_date":"2012-02-23","scope":"insider"},{"id":2583199,"accession":"0001237899-12-000030","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001237899-12-000030","line_url":"/filing/0001237899-12-000030#line-16","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS INC","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001377247","owner_name":"Powchik Peter","owner_url":"/insider/0001377247","role":"Officer (SVP Clinical Development & Reg)","officer_title":"SVP Clinical Development & Reg","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10800.0,"shares_display":"10,800","price_per_share":95.46,"price_display":"95.46","price_state":"stated","total_value":1030968.0,"total_display":"1,030,968.00","shares_owned_after":49398.0,"shares_owned_after_display":"49,398","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-02-22","filed_date":"2012-02-23","scope":"insider"},{"id":2583193,"accession":"0001237899-12-000030","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001237899-12-000030","line_url":"/filing/0001237899-12-000030#line-15","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS INC","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001377247","owner_name":"Powchik Peter","owner_url":"/insider/0001377247","role":"Officer (SVP Clinical Development & Reg)","officer_title":"SVP Clinical Development & Reg","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9600.0,"shares_display":"9,600","price_per_share":97.58,"price_display":"97.58","price_state":"stated","total_value":936768.0,"total_display":"936,768.00","shares_owned_after":16344.0,"shares_owned_after_display":"16,344","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-02-22","filed_date":"2012-02-23","scope":"insider"}],"next_cursor":"2012-02-22|2583193","ledger_fault":false,"count":{"value":54,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":54,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":54},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000872589","name":"REGENERON PHARMACEUTICALS INC","url":"/issuer/0000872589","role":"Officer (SVP Clinical Development & Reg)","n_filings":12,"first_seen":"2011-07-26","last_seen":"2015-08-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001377247","retrieved_at":"2026-08-21T09:44:10+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}